Abaxis Inc Quick Ratio (ABAX) starting from the fourth quarter 2018 to fourth quarter 2017, Financial Strength Trends, Rankings, Financial Ratios - CSIMarket
CSIMarket
 


Abaxis Inc  (ABAX)

Abaxis Inc's Quick Ratio

ABAX's quarterly Quick Ratio and Cash & cash equivalent, Current Liabilities growth


In the wake of the increase in Current Liabilities in the fourth quarter 2018, Quick Ratio fell to 3.8 below Abaxis Inc average.

Within Laboratory Analytical Instruments industry 4 other companies have achieved higher Quick Ratio than Abaxis Inc in fourth quarter 2018. While Quick Ratio total ranking in the fourth quarter 2018 has deteriorated compared to the prior quarter from 399 to 789.

Explain Quick Ratio?
How much Cash & cash equivalents ABAX´s has?
What are ABAX´s Current Liabilities?




ABAX Quick Ratio (Mar 31 2018)
Q4
(Dec 31 2017)
Q3
(Sep 30 2017)
Q2
(Jun 30 2017)
Q2
(Mar 31 2017)
Q4
Y / Y Current Liabilities Change 31.21 % 152.04 % 21.7 % 29.36 % 128.47 %
Y / Y Cash & cash equivalent Change 16.72 % 17.16 % 2.23 % -25.99 % 10.09 %
Quick Ratio MRQ 3.8 3.81 8.43 4.6 4.27
ABAX's Total Ranking # 789 # 399 # 455 # 652 #
Seq. Current Liabilities Change 3.53 % 140.17 % -19.52 % -34.44 % 98.88 %
Seq. Cash & cash equivalent Change 3.2 % 8.65 % 47.58 % -29.46 % 3.59 %



Quick Ratio fourth quarter 2018 Company Ranking
Within: No.
Laboratory Analytical Instruments Industry # 5
Healthcare Sector # 341
Overall Market # 789


Quick Ratio Statistics
High Average Low
6.09 4.27 2.82
(Mar 31 2014)   (Dec 31 2012)




Financial Statements
Abaxis Inc's Current Liabilities $ 44 Millions Visit ABAX's Balance sheet
Abaxis Inc's Cash & cash equivalent $ 167 Millions Visit ABAX's Balance sheet
Source of ABAX's Sales Visit ABAX's Sales by Geography


Cumulative Abaxis Inc's Quick Ratio

ABAX's Quick Ratio for the trailling 12 Months

ABAX Quick Ratio

(Mar 31 2018)
12 Months
(Dec 31 2017)
12 Months
(Sep 30 2017)
12 Months
(Jun 30 2017)
12 Months
(Mar 31 2017)
12 Months
Y / Y Current Liabilities TTM Growth 54.01 % 83.46 % 48.92 % 45.35 % 40.59 %
Y / Y Cash & cash equivalent TTM Growth 2.74 % 0.84 % -2.63 % -0.97 % 7.07 %
Quick Ratio TTM 4.59 4.8 5.9 6.08 6.88
Total Ranking TTM # 4418 # 285 # 333 # 4368 #
Seq. Current Liabilities TTM Growth 9.04 % 28.46 % 3.63 % 6.09 % 29.9 %
Seq. Cash & cash equivalent TTM Growth 4.31 % 4.46 % 0.61 % -6.29 % 2.38 %


On the trailing twelve months basis Due to rise in Current Liabilities in the Q4 2018 to $43.88 millions, cumulative Quick Ratio decreased to 4.59 above the ABAX average Quick Ratio.
Quick Ratio is the average cumulative value over the last four quarters.

Among companies operating within Laboratory Analytical Instruments industry 21 other companies have achieved higher Quick Ratio than Abaxis Inc. While Quick Ratio total ranking has deteriorated compared to the previous twelve months ending in the third quarter 2017 from 285 to 4418.

Explain Quick Ratio?
How much Cash & cash equivalents ABAX´s has?
What are ABAX´s Current Liabilities?

TTM Quick Ratio Company Ranking
Within: No.
Within the Laboratory Analytical Instruments Industry # 22
Healthcare Sector # 769
Within the Market # 4418


trailing twelve months Quick Ratio Statistics
High Average Low
5.39 4.3 3.42
(Mar 31 2014)   (Dec 31 2012)




Companies with similar Quick Ratio in the quarter ending Mar 31 2018, within Laboratory Analytical Instruments Industry Quick RatioMar 31 2018 MRQ Cash & cash equivalentMar 31 2018 MRQ Current Liabilities
Astrotech Corp  6.75 $ 6.280  Millions$ 0.930  Millions
Waters Corporation  6.06 $ 2,551.873  Millions$ 420.861  Millions
Reflect Scientific Inc  4.40 $ 0.246  Millions$ 0.056  Millions
Abaxis Inc  3.80 $ 166.783  Millions$ 43.880  Millions
Pacific Biosciences Of California Inc   3.18 $ 79.260  Millions$ 24.948  Millions
Illumina Inc   3.02 $ 2,373.000  Millions$ 787.000  Millions
Misonix Inc   2.95 $ 12.310  Millions$ 4.166  Millions
Standard Biotools Inc   2.87 $ 47.254  Millions$ 16.442  Millions
Quanterix Corporation  2.78 $ 65.231  Millions$ 23.434  Millions
Agilent Technologies inc   2.67 $ 3,011.000  Millions$ 1,127.000  Millions
Lifeloc Technologies Inc   2.66 $ 2.706  Millions$ 1.017  Millions
Bio rad Laboratories Inc   1.68 $ 768.493  Millions$ 456.198  Millions
Eyepoint Inc   1.24 $ 16.346  Millions$ 13.172  Millions

Date modified: 2026-07-06T17:55:05+00:00



Help

About us

Products

Data downloads

API

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research.

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com

Disclaimer: Information provided by CSIMarket.com is for informational purposes only and does not constitute investment advice, recommendation, or solicitation to buy or sell any security.

© 2026 CSIMarket.com — Proprietary financial dataset. All rights reserved. Redistribution or automated extraction prohibited.